The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53
about
Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem CellsMicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenograftsA transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomideCombining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.Mitochondria-mediated apoptosis in mammals.Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cellsUpregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma.Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancerUnderstanding sensitivity to BH3 mimetics: ABT-737 as a case study to foresee the complexities of personalized medicine.Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC.Bcl‑2 associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells.BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860
Q28084243-7C364867-20EE-465D-8483-E041A3CE5CB2Q28280193-265D1DEC-9930-4297-9B14-6E97E885110EQ28538631-87C8EA46-4CCD-4021-8B40-93EBDD265BECQ35781382-4D4D627E-B43B-43CF-BA2A-A09BBAC60E9EQ37708989-B45F7E66-91CE-4928-90BA-37E5F6BB925DQ38138933-82647959-98B6-4368-96A3-66CB9146DA64Q38235124-8962B524-8504-42B6-BDA2-C19812F120CEQ38944587-9CE4EE0D-2CDB-4D6F-ACFB-9E6DAF543329Q41098467-17E2ED63-F999-43DC-A081-28A825D2FF2DQ41470758-7935DCBF-C584-4F03-BCEC-3D763179D629Q41517649-0B6C2AA3-A445-438C-8D00-52316B09D51AQ42117299-529A4272-0EB3-4D6D-A00A-BA080357B0EBQ42201282-FB7D8642-D81D-406E-8E22-85CE3EE1F924Q42425463-DEAEE2C5-85AD-47C5-A7AF-43E89C8C28E7Q42679623-CF0D4B2D-EE2C-4738-AB67-8B85387D5C3AQ48175785-631EB044-B015-495B-BE2F-351EB6C50CE8Q51746852-EB81B6CD-AD5C-4D68-A336-A1DA5A83D5A4Q54937151-09EAD9C9-D51C-48F7-AAAC-0DB03EE2710DQ58763373-4F9FB4CE-2B03-4CB0-B4FF-4167B406414F
P2860
The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The combination of BH3-mimetic ...... anoma cells independent of p53
@ast
The combination of BH3-mimetic ...... anoma cells independent of p53
@en
The combination of BH3-mimetic ...... anoma cells independent of p53
@nl
type
label
The combination of BH3-mimetic ...... anoma cells independent of p53
@ast
The combination of BH3-mimetic ...... anoma cells independent of p53
@en
The combination of BH3-mimetic ...... anoma cells independent of p53
@nl
prefLabel
The combination of BH3-mimetic ...... anoma cells independent of p53
@ast
The combination of BH3-mimetic ...... anoma cells independent of p53
@en
The combination of BH3-mimetic ...... anoma cells independent of p53
@nl
P2093
P2860
P1433
P1476
The combination of BH3-mimetic ...... anoma cells independent of p53
@en
P2093
David A Cooper
David A Norris
Katie A Partyka
Mayumi Fujita
Nathaniel B Goldstein
Steven N Reuland
P2860
P304
P356
10.1371/JOURNAL.PONE.0024294
P407
P577
2011-08-29T00:00:00Z